Official announcements
Search narrowed by
Recall
|
Medicines
|
29/11/2010
The marketing authorization holder informed its supplied customers by letters dated October 29 and November 25, 2010, that the sterility of the products cannot be guaranteed for the batches listed above.
Replacement
|
Medicines
|
18/11/2010
The marketing authorization holder has informed its supplied customers by letter dated 18.11.2010 that due to 5 complaints about visible particles after reconstitution of the product, which occurred in two batches of this medicinal speciality, the…
Recall
|
Medicines
|
17/11/2010
Ebewe/Sandox has initiated a voluntary recall of certain lots of ebetraxate as a precautionary measure. See related file.
Recall
|
Medicines
|
17/10/2010
Ebewe/Santoz has initiated a voluntary recall of certain lots of 5-fluorouracil as a precautionary measure. See related file.
Medicines
|
28/09/2010
Notice of supply difficulties for PegIntron Powder and Solvent for Solution for Injection. See related file.
Recall
|
Medicines
|
29/09/2008
The following quality defect has been identified in the drug product Ionsys (Fentanyl) 40 microgram per dose iontophoretic transdermal system: A defect in the IONSYS systems may potentially cause the system to self-activate. See related files.
Replacement
|
Medicines
|
18/08/2008
Exchange of unbuffered and weakly buffered infusion solutions. See associated files.
Medicines
|
18/01/2008
Communication from the Federal Office for Safety in Health Care on Gardasil. You related file.
Recall
|
Medicines
|
06/11/2007
Information on the suspension of marketing of parenterally administrable drug products containing aprotinin. See related files.